The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 92.50
KAKU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

19 Aug 2020 07:00

RNS Number : 4947W
Kakuzi Ld
19 August 2020
 

KAKUZI PLC

 

 

EXTRACT FROM THE INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD OF SIX MONTHS TO 30 JUNE 2020

The unaudited results for the Kakuzi Group for the period of six months to 30 June 2020 and the comparative figures for the previous year are as follows:

Condensed Consolidated Statement of Profit or Loss and other Comprehensive Income

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2020

 

30 June 2019

 

 

 

 

 

Shs'000

 

Shs'000

 

 

 

 

 

 

 

 

 

 

Sales

 

 

889,909

 

619,463

 

 

 

 

 

 

 

 

 

 

Profit before fair value gain in non-current biological assets and income tax

 

 

186,022

 

334,857

 

 

Fair value gain in non-current biological assets

 

 

18,095

 

20,225

 

 

 

 

 

 

 

 

 

 

Profit before income tax

 

 

204,117

 

355,082

 

 

Income tax credit/(expense)

 

 

68,670

 

(109,501

)

 

 

 

 

 

 

 

 

 

Profit for the period

 

 

272,787

 

245,581

 

 

 

 

 

 

 

 

 

 

  Other Comprehensive Income:

 

 

 

 

 

 

 

Items that are not reclassified to profit or loss:

 

 

 

 

 

 

 

Remeasurement of post-employment benefit obligations (net of tax)

 

 

-

 

-

 

 

Total comprehensive income

 

 

272,787

 

245,581

 

 

 

 

 

 

 

 

 

 

 

 

 

Shs

 

Shs

 

 

Earnings per share (Shs):

 

 

 

 

 

 

 

Basic and diluted earnings per ordinary share

 

 

13.92

 

12.53

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Cash flows

 

 

 

 

 

 

 

 

 

 

 

 

 

30 June 2020

 

30 June 2019

 

 

 

 

 

Shs'000

 

Shs'000

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the year

 

 

1,696,130

 

1,500,935

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(226,022

)

(86,944

)

 

Net cash used in investing activities

 

 

(195,489

)

(235,314

)

 

Net cash used in financing activities

 

 

(274,413

)

(176,400

)

 

Effect of exchange rate differences on cash and cash equivalents

 

 

12,856

 

1,911

 

 

Decrease in cash and cash equivalents

 

 

(683,068

)

(496,747

)

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the year

 

 

1,013,062

 

1,004,188

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Financial Position

 

 

 

 

 

 

 

 

 

Audited

 

 

 

 

 

 

30 June 2020

 

30 June 2019

 

31 December 2019

 

 

 

 

 

 

Shs'000

 

Shs'000

 

Shs'000

 

EQUITY

 

 

 

 

 

 

 

 

 

 

Share capital

 

 

 

 

98,000

 

98,000

 

98,000

 

Other reserves

 

 

 

 

31,463

 

19,653

 

31,463

 

Retained earnings

 

 

 

 

5,087,249

 

4,621,004

 

4,814,462

 

Proposed dividends

 

 

 

 

-

 

-

 

274,400

 

Total equity

 

 

 

 

5,216,712

 

4,738,657

 

5,218,325

 

Non-current liabilities

 

 

 

 

914,503

 

972,478

 

1,007,047

 

 

 

 

 

 

6,131,215

 

5,711,135

 

6,225,372

 

REPRESENTED BY

 

 

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

3,920,666

 

3,745,481

 

3,868,015

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

1,568,992

 

1,371,745

 

896,890

 

Cash and cash balances

 

 

 

 

1,013,062

 

1,004,188

 

1,696,130

 

Current liabilities

 

 

 

 

(371,505

)

(410,279

)

(235,663

)

Net current assets

 

 

 

 

2,210,549

 

1,965,654

 

2,357,357

 

 

 

 

 

 

6,131,215

 

5,711,135

 

6,225,372

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Changes in Equity

 

 

 

 

 

 

Share

capital

 

Other reserves

 

Retained earnings

 

Proposed dividends

 

Total Equity

 

 

Shs'000

 

Shs'000

 

Shs'000

 

Shs'000

 

Shs'000

 

 

 

 

 

 

 

 

 

 

 

At start of the year

98,000

 

31,463

 

4,814,462

 

274,400

 

5,218,325

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the period

-

 

-

 

272,787

 

-

 

272,787

 

Dividends paid

-

 

-

 

-

 

(274,400

)

(274,400

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At end of period

98,000

 

31,463

 

5,087,249

 

-

 

5,216,712

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RESULTS:

 

The profit before tax for the period to June 2020 was KSh 204.1 million compared to a profit of KSh 355.1 million for the same period last year. This is principally due to a financial provision write back in 2019.

 

During the first half of the year, avocado profits are on a par with 2019, macadamia profits are greater, and our tea operations made an operating loss of KSh 11.3 million compared to a loss of KSh 1.1 million in 2019.

 

The profit after tax for the period to 30 June 2020 was KSh 272.8 million compared to a profit of KSh 245.5 million for the same period last year. This is principally due to the release of deferred tax provision in view of the reduction of the Corporate tax rate to 25% from 30% by the Government.

 

The Directors do not recommend the payment of an interim dividend.

 

BY ORDER OF THE BOARD

 

G H MCLEAN

CHAIRMAN

18 AUGUST 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BSGDIDUBDGGI
12
Date   Source Headline
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
18th Mar 20117:39 amRNSFinal Results 2010
26th Jan 20117:00 amRNSPublic Announcement
25th Aug 20104:55 pmRNSHalf Yearly Report
12th Mar 20107:00 amRNSFinal Results
26th Aug 20097:00 amRNSHalf Yearly Report
5th Mar 20094:21 pmRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.